Ipca Labs appoints Dr Nagaji Ambabhai Vekariya as President - CRD

Published On 2025-06-16 12:19 GMT | Update On 2025-06-16 12:22 GMT

Ipca Labs has announced that Dr Nagaji Ambabhai Vekariya has joined the Company as President - CRD.

Dr Vekariya brings with him a professional experience of over 23 years. He started his career with Alembic Pharmaceuticals Ltd in the year 2001 and thereafter worked with companies like Glenmark Pharmaceuticals, Lupin Ltd, Aurobindo Pharma Ltd, Macleods Pharmaceuticals Ltd. & Neuland Laboratories Ltd.

Prior to joining Ipca, he was associated with Sekhmet Pharmaventures Pvt Ltd as Head - API & Formulations R&D.

Throughout his career, he has successfully led complex research initiatives, enabled global regulatory filings and played a pivotal role in advancing long term innovation strategies.

Dr Vekariya has completed his PhD in Organic Chemistry from Saurashtra University.

In March, the Medical Dialogues team reported that Ipca Labs appointed Saidutta Nanda as President - Human Resources.

Established in 1949, lpca is a pharmaceutical company. lpca is vertically integrated and produces finished dosage forms and active pharmaceutical ingredients. For more than 70 years, lpca has been a crucial healthcare partner in over 120 countries across the globe. lpca markets its branded formulations in India and rest of the world markets and generic formulations in United States, Europe, United Kingdom, Canada, Australia & New Zealand. APls manufactured by lpca are marketed across the globe.

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Ipca Labs appoints Dr Nagaji Ambabhai Vekariya as President - CRD

Similar News

DoP again extends timeline for submitting applications under PLI Scheme for pharma sector

Alembic Pharma ropes in G Krishnan as CFO

Harsh V Trehan named CHRO, Executive Vice President at GSK India

Sun Pharma Advanced Research Company incorporates wholly owned subsidiary Genokine Biotech

42 dead, 8 still missing in Sigachi pharma plant explosion

Akums Drugs and Pharma: Jitendra Mishra steps down as Senior Vice President - IT

Biocon Biologics gets marketing nods in UK for Vevzuo, Evfraxy

Indian pharma exports strong at USD 4.9 billion in April-May: Pharmexcil